Evidence map›Paper›PMID 22739110›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2012

Acetylcholinesterase deficiency contributes to neuromuscular junction dysfunction in type 1 diabetic neuropathy.

Carmen C Garcia, Joseph G Potian, Kormakur Hognason, Baskaran Thyagarajan, Lester G Sultatos, Nizar Souayah, Vanessa H Routh, Joseph J McArdle

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cholinesterases in Tripartite Neuromuscular Synapse.Frontiers in molecular neuroscience · 2021
    Review
  5. Reaching task performance is associated to neuromuscular junction adaptations in rats with induced diabetes mellitus.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2020
    Article
  6. Acupotomy Alleviates Energy Crisis at Rat Myofascial Trigger Points.Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Carmen C GarciaDept. of Pharmacology and Physiology, New Jersey Medical School-UMDNJ, MSB-I626, 185 South Orange Ave., Newark, NJ 07101-1709, USA.
Joseph G Potian
Kormakur Hognason
Baskaran Thyagarajan
Lester G Sultatos
Nizar Souayah
Vanessa H Routh
Joseph J McArdle
Rutgers, The State University of New Jersey · US

Funding

Ion Channels and Chemicals Controlling Synapse StabilityR01NS045979 · NINDS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI MCARDLE, JOSEPH J · 2003 to 2006
$1.3M
NINDS NIH HHS R01 NS045979NINDS NIH HHS R01-NS-045979
6 · The paper itself

Abstract

Diabetic neuropathy is associated with functional and morphological changes of the neuromuscular junction (NMJ) associated with muscle weakness. This study examines the effect of type 1 diabetes on NMJ function. Swiss Webster mice were made diabetic with three interdaily ip injections of streptozotocin (STZ). Mice were severely hyperglycemic within 7 days after the STZ treatment began. Whereas performance of mice on a rotating rod remained normal, the twitch tension response of the isolated extensor digitorum longus to nerve stimulation was reduced significantly at 4 wk after the onset of STZ-induced hyperglycemia. This mechanical alteration was associated with increased amplitude and prolonged duration of miniature end-plate currents (mEPCs). Prolongation of mEPCs was not due to expression of the embryonic acetylcholine receptor but to reduced muscle expression of acetylcholine esterase (AChE). Greater sensitivity of mEPC decay time to the selective butyrylcholinesterase (BChE) inhibitor PEC suggests that muscle attempts to compensate for reduced AChE levels by increasing expression of BChE. These alterations of AChE are attributed to STZ-induced hyperglycemia since similar mEPC prolongation and reduced AChE expression were found for db/db mice. The reduction of muscle end-plate AChE activity early during the onset of STZ-induced hyperglycemia may contribute to endplate pathology and subsequent muscle weakness during diabetes.

Indexed as

AcetylcholinesteraseAnimalsButyrylcholinesteraseCholinesterase InhibitorsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1Diabetic NeuropathiesGPI-Linked ProteinsHyperglycemiaMaleMiceMotor EndplateMuscle WeaknessNeuromuscular Junction DiseasesPhysostigmineAcetylcholinesteraseAche protein, mouseButyrylcholinesteraseCholinesterase InhibitorsGPI-Linked ProteinsphenethylcymserinephenserinePhysostigmine

Identifiers

PMID22739110
PMCPMC3423102
OpenAlexW2154595837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.